Journal article

Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS

Jasminka Sterjovski, Melissa J Churchill, Anne Ellett, Lachlan R Gray, Michael J Roche, Rebecca L Dunfee, Damian Fj Purcell, Nitin Saksena, Bin Wang, Secondo Sonza, Steven L Wesselingh, Ingrid Karlsson, Eva-Maria Fenyo, Dana Gabuzda, Anthony L Cunningham, Paul R Gorry

RETROVIROLOGY | BMC | Published : 2007


BACKGROUND: CCR5-restricted (R5) human immunodeficiency virus type 1 (HIV-1) variants cause CD4+ T-cell loss in the majority of individuals who progress to AIDS, but mechanisms underlying the pathogenicity of R5 strains are poorly understood. To better understand envelope glycoprotein (Env) determinants contributing to pathogenicity of R5 viruses, we characterized 37 full-length R5 Envs from cross-sectional and longitudinal R5 viruses isolated from blood of patients with asymptomatic infection or AIDS, referred to as pre-AIDS (PA) and AIDS (A) R5 Envs, respectively. RESULTS: Compared to PA-R5 Envs, A-R5 Envs had enhanced fusogenicity in quantitative cell-cell fusion assays, and reduced sensi..

View full abstract